CLAIM CARD
The evidence for ACE inhibitor effects on frailty is derived exclusively from a preclinical model. Translational relevance to humans remains uncertain. The intervention involved a dose of 30 mg/kg/day administered via feed. The primary outcome assessed was the attenuation of frailty development in middle-aged animals.
Evidence grade: exploratory
Contradiction status: none
Publication: 9ab2e887-2e5b-429a-8d89-fd6d7813a028
Provenance: Derivation Web chain
Citation Support
source_1Lin 2026source_2Din 2026source_3Spiegeleer 2025source_4Shen 2025source_5Bene 2025